Last updated on December 2019

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease


Brief description of study

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

Clinical Study Identifier: NCT03467958

Find a site near you

Start Over

Digestive Disease Associates, PA

Catonsville, MD United States
  Connect »

Johns Hopkins University

Baltimore, MD United States
9.82miles
  Connect »

Johns Hopkins Bayview Medical Center

Baltimore, MD United States
9.82miles
  Connect »

Woodholme Gastroenterology Associates

Glen Burnie, MD United States
9.98miles
  Connect »